Mitochondrial function and dysfunction: An update

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 598-607

  Davis, Robert E ^a   Williams, Michael ^b  

^a 3 D Pharmaceutical Consultants ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; BICARBONATE; CARNITINE; CHOLINE TETRATHIOMOLYBDATE; COCARBOXYLASE; CREATINE; DEOXYCORTICOSTERONE ACETATE; DICHLOROACETIC ACID; DOCOSAHEXAENOIC ACID; ELESCLOMOL; FOLIC ACID; ICOSAPENTAENOIC ACID; ISOSORBIDE; LACTIC ACID; METHYLENE BLUE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NANOPARTICLE; NATURAL PRODUCT; NUTRACEUTICAL; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; SUCCINIC ACID; TETRAHYDROLIPSTATIN; TROLOX C; UBIDECARENONE; UNINDEXED DRUG; VITAMIN D;

AUTISM; AUTOPHAGY; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CELL DEATH; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DEVELOPMENT; DRUG TARGETING; GENE THERAPY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MITOCHONDRIAL GENETICS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DEATH; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84865165560     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.192104     Document Type: Review

References (97)

1. Akar FG and O'Rourke B (2011) Mitochondria are sources of metabolic sink and arrhythmias. Pharmacol Ther 131:287-294.
2. Austin S, Klimcakova E, and St-Pierre J (2011) Impact of PGC-1α on the topology and rate of superoxide production by the mitochondrial electron transport chain. Free Radic Biol Med 51:2243-2248.
3. Azzolin L, Antolini N, Calderan A, Ruzza P, Sciacovelli M, Marin O, Mammi S, Bernardi P, and Rasola A (2011) Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore. PLoS One 6:e16280.
4. Baines CP (2010) Role of the mitochondrion in programmed necrosis. Front Physiol 1:156.
5. Ballinger SW (2005) Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 38:1278-12795.
6. Bertram R, Gram Pedersen M, Luciani DS, and Sherman A (2006) A simplified model for mitochondrial ATP production. J Theor Biol 243:575-586. (Pubitemid 44708225)
7. Biémont C (2010) A brief history of the status of transposable elements: from junk DNA to major players in evolution. Genetics 186:1085-1093.
8. Bordet T, Berna P, Abitbol J-L, and Pruss RM (2010) Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals 3:345-368.
9. Bouitbir J, Charles A-L, Echaniz-Laguna A, Kindo M, Daussin F, Auwerx J, Piquard F, Geny B, and Zoll J (2011) Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Eur Heart J 33:1397-1407.
10. Castellani RJ, Lee HG, Siedlak SL, Nunomura A, Hayashi T, Nakamura M, Zhu X, Perry G, and Smith MA (2009) Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimers Dis 18:447-452.
11. Chan DC (2006) Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 22:79-99.
12. Copeland WC (2008) Inherited mitochondrial diseases of DNA replication. Annu Rev Med 59:131-146.
13. Cooper O, Seo H, Andrabi S, Guardia-Laguarta C, Graziotto J, Sundberg M, McLean JR, Carrillo-Reid L, Xie Z, Osborn T. et al., (2012) Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med 4:141ra90.
14. Couzin-Frankel J (2011) Aging genes: the sirtuin story unravels. Science 334:1194-1198.
15. Cudkowicz M, Bozik ME, Ingersoll EW, Miller R, Mitsumoto H, Shefner J, Moore DH, Schoenfeld D, Mather JL, Archibald D, et al. (2011) The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nat Med 17:1652-1656.
16. Dagda RK, Zhu J, and Chu CT (2009) Mitochondrial kinases in Parkinson's disease: converging insights from neurotoxin and genetic models. Mitochondrion 9:289-298.
17. de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, and Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis 10:89-109. (Pubitemid 44401370)
18. De Taboada L, Yu J, El-Amouri S, Gattoni-Celli S, Richieri S, McCarthy T, Streeter J, and Kindy MS (2011) Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice. J Alzheimers Dis 23:521-535.
19. Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D, and dimebon investigators (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 372:207-215. (Pubitemid 351978110)
20. Durazo SA and Kompella UB (2012) Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion 12:190-201.
21. Durieux J, Wolff S, and Dillin A (2011) The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144:79-91.
22. Edinger AL and Thompson CB (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16:663-669. (Pubitemid 39463117)
23. Eichner LJ and Giguère V (2011) Estrogen related receptors (ERRs): a new dawn in transcriptional control of mitochondrial gene networks. Mitochondrion 11:544-552.
24. Ferrari LF, Chum A, Bogen O, Reichling DB, and Levine JD (2011) Role of Drp1, a key mitochondrial fission protein, in neuropathic pain. J Neurosci 31:11404-11410.
25. Fink BD, Herlein JA, Yorek MA, Fenner AM, Kerns RJ, and Sivitz WI (2012) Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells. J Pharmacol Ex Ther 342:709-719.
26. Finsterer J (2010) Treatment of mitochondrial disorders. Eur J Paediatr Neurol 14:29-44.
27. Fulda S, Galluzzi L, and Kroemer G (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447-464.
28. Geser F, Martinez-Lage M, Kwong LK, Lee VM, and Trojanowski JQ (2009) Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol 256:1205-1214.
29. Gilliam LAA and Neufer PD (2012) Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key? J Pharmacol Exp Ther 342:631-636.
30. Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, et al., (2012) Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 12:77-85.
31. Haas RH, Parikh S, Falk, MJ, Saneto RP, Wolff NI, Darin N, Wong LJ, Cohen BH, and Naviaux RK (2008) The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94:16-37.
32. Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46:821-831.
33. Halliwell B (2011) Free radicals and antioxidants-quo vadis? Trends Pharmacol Sci 32:125-130.
34. Huang Q and Figueiredo-Pereira ME (2010) Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis 15:1292-1311.
35. Hüttemann M, Pecina P, Rainbolt M, Sanderson TH, Kagan VE, Samavati L, Doan JW, and Lee I (2011) The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: From respiration to apoptosis. Mitochondrion 11:369-381.
36. Javadov S, Hunter JC, Barreto-Torres G, and Parodi-Rullan R (2011) Targeting the mitochondrial permeability transition: cardiac ischemia-reperfusion versus carcinogenesis. Cell Physiol Biochem 27:179-190.
37. Johri A and Beal MF (2012) Mitochondrial dysfunction in neurodegenerative diseases. J Pharmacol Exp Ther 342:619-630.
38. Jones S, Holm T, Mäger I, Langel U, and Howl J (2010) Characterization of bioactive cell penetrating peptides from human cytochrome c: protein mimicry and the development of a novel apoptogenic agent. Chem Biol 17:735-744.
39. Kerr DS (2010) Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab 99:246-255.
40. Kitsis RN and Molkentin JD (2010) Apoptotic cell death "Nixed" by an ER mitochondrial necrotic pathway. Proc Natl Acad Sci U S A 107:9031-9032.
41. Koopman WJ, Willems PH, and Smettink JA (2012) Monogenic mitochondrial disorders. N Engl J Med 366:1132-1141.
42. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3-11.
43. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:481-484. (Pubitemid 40994689)
44. Kumar S, Kostin S, Flacke JP, Reusch HP, and Ladilov Y (2009) Soluble adenylyl cyclase controls mitochondria-dependent apoptosis in coronary endothelial cells. J Biol Chem 284:14760-14768.
45. Kunji ER and Crichton PG (2010) Mitochondrial carriers function as monomers. Biochim Biophys Acta 1797:817-831.
46. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al., (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127:1109-1122. (Pubitemid 44894520)
47. Lapointe J and Hekimi S (2010) When a theory of aging ages badly. Cell Mol Life Sci 67:1-8.
48. Lax NZ, Turnbull DM, and Reeve AK (2011) Mitochondrial mutations: newly discovered players in neuronal degeneration. Neuroscientist 17:645-658.
49. Lee JY, Nagano Y, Taylor JP, Lim KL, and Yao TP (2010) Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol 189:671-679.
50. Legros F, Malka F, Frachon P, Lombès A, and Rojo M (2004) Organization and dynamics of human mitochondrial DNA. J Cell Sci 117:2653-2662. (Pubitemid 38997249)
51. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452. (Pubitemid 38495942)
52. Maldonado EN and LeMasters JL (2012) Warburg revisited: regulation of mitochondrial metabolism by voltage-dependent anion channels in cancer cells. J Pharmacol Exp Ther 342:637-641.
53. Martin LJ, Adams NA, Pan Y, Price A, and Wong M (2011) The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation. J Neurosci 31:359-370.
54. McBride HM, Neuspiel M, and Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16:R551-R560.
55. Mochel F and Haller RG (2011) Energy deficit in Huntington's disease: why it matters. J Clin Invest 121:493-499.
56. Moreira PI, Carvalho C, Zhu X, Smith MA, and Perry G (2010) Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 1802:2-10.
57. Moreira PI, Santos MS, Seiça R, and Oliveira CR (2007) Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci 257: 206-214. (Pubitemid 46856489)
58. Mullane K and Williams M (2012) Translational semantics and infrastructure: another search for the emperor's new clothes? Drug Discov Today 17:459-468.
59. Naviaux RK (2012) Oxidative shielding or oxidative stress? J Pharmacol Exp Ther 342:608-618.
60. Ong SB and Hausenloy DJ (2010) Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 88:16-29.
61. Pamplona R (2011) Mitochondrial DNA damage and animal longevity: insights from comparative studies. J Aging Res 2011:807108.
62. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, et al. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402-409. (Pubitemid 44069585)
63. Pereira CV, Lebiedzinska M, Wieckowski MR, and Oliveira PJ (2012) Regulation and protection of mitochondrial physiology by sirtuins. Mitochondrion 12:66-76.
64. Poljsak B (2011) Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev 2011:194586.
65. Reddy PH (2009) The role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease. CNS Spectr 14:8-13; discussion 16-18.
66. Reyes NA, Fisher JK, Austgen K, VandenBerg S, Huang EJ, and Oakes SA (2010) Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis. J Clin Invest 120:3673-3679.
67. Rodriguez-Enriquez S, He L, and Lemasters JJ (2004) Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int J Biochem Cell Biol 36:2463-2472. (Pubitemid 39119759)
68. Roestenberg P, Manjeri GR, Valsecchi F, Smeitink JA, Willems PH, and Koopman WJ (2012) Pharmacological targeting of mitochondrial complex I deficiency: the cellular level and beyond. Mitochondrion 12:57-65.
69. Rossignol DA and Frye RE (2012) A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17:389-401.
70. Sabbagh MN and Berk C (2010) Latrepirdine for Alzheimer's disease: trials and tribulations. Future Neurol 5:645-665.
71. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, et al. (2011) Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470:359-365.
72. Schapira AH (2006) Mitochondrial disease. Lancet 368:70-82.
73. Schatz G (2007) The magic garden. Annu Rev Biochem 76:673-678.
74. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, Hetz C, Danial NN, Moskowitz MA, and Korsmeyer SJ (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A 102:12005-12010. (Pubitemid 41291119)
75. Schon EA, DiMauro S, Hirano M, and Gilkerson RW (2010) Therapeutic prospects for mitochondrial disease. Trends Mol Med 16:268-276.
76. Sheridan C and Martin SJ (2010) Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 10:640-648.
77. Shoshan-Barmatz V and Ben-Hail D (2012) VDAC, a multi-functional mitochondrial protein as a pharmacological target. Mitochondrion 12:24-34.
78. Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR, et al. (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377-382.
79. Stacpoole PW (2011) Why are there no proven therapies for genetic mitochondrial diseases? Mitochondrion 11:679-685.
80. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148:213-227.
81. Suzuki Y, Inoue T, and Ra C (2010) NSAIDs, mitochondria and calcium signaling: special focus on aspirin/salicylates. Pharmaceuticals 3:1594-1613.
82. Swerdlow RH and Khan SM (2009) The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 218:308-315.
83. Szendroedi J, Phielix E, and Roden M (2012) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8:92-103.
84. Szewczyk A and Wojtczak L (2002) Mitochondria as a pharmacological target. Pharmacol Rev 54:101-127. (Pubitemid 34211027)
85. Tillement L, Lecanu L, and Papadopoulos V (2011) Alzheimer's disease: effects of β-amyloid on mitochondria. Mitochondrion 11:13-21.
86. Varanyuwatana P and Halestrap AP (2012) The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 12:120-125.
87. Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482-1488.
88. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407.
89. Wallace DC and Fan W (2010) Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10:12-31.
90. Wang C and Youle RJ (2009) The role of mitochondria in apoptosis*. Annu Rev Genet 43:95-118.
91. Wang Z, Jiang H, Chen S, Du F, and Wang X (2012) The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148:228-243.
92. Williams M and Coyle JT (2012) Historical perspectives on the discovery and development of drugs to treat neurological disorders, in Translational Neuroscience Applications in Psychiatry, Neurology and Neurodevelopmental Disorders (Barrett JE, Coyle JT and Williams M eds) pp 129-148, Cambridge University Press, Cambridge, UK.
93. Witte ME, Geurts JJ, de Vries HE, van der Valk P, and van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411-418.
94. Yao J, Du H, Yan S, Fang F, Wang C, Lue LF, Guo L, Chen D, Stern DM, Gunn Moore FJ, et al. (2011) Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. J Neurosci 31:2313-2320.
95. Youle RJ and Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12:9-14.
96. Zamzami N, Larochette N, and Kroemer G (2005) Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ 12:1478-1480. (Pubitemid 41553982)
97. Zhang S, Hedskog L, Petersen CA, Winblad B, and Ankarcrona M (2010) Dimebon (latrepirdine) enhances mitochondrial function and protects neuronal cells from death. J Alzheimers Dis 21:389-402.